BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND HOXC13, HOX3G, 3229, ENSG00000123364, P31276, HOX3
11 results:

  • 1. Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.
    Lozano-Rabella M; Garcia-Garijo A; Palomero J; Yuste-Estevanez A; Erhard F; Farriol-Duran R; Martín-Liberal J; Ochoa-de-Olza M; Matos I; Gartner JJ; Ghosh M; Canals F; Vidal A; Piulats JM; Matías-Guiu X; Brana I; Muñoz-Couselo E; Garralda E; Schlosser A; Gros A
    Clin Cancer Res; 2023 Jun; 29(12):2250-2265. PubMed ID: 36749875
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Saura C; Hlauschek D; Oliveira M; Zardavas D; Jallitsch-Halper A; de la Peña L; Nuciforo P; Ballestrero A; Dubsky P; Lombard JM; Vuylsteke P; Castaneda CA; Colleoni M; Santos Borges G; Ciruelos E; Fornier M; Boer K; Bardia A; Wilson TR; Stout TJ; Hsu JY; Shi Y; Piccart M; Gnant M; Baselga J; de Azambuja E
    Lancet Oncol; 2019 Sep; 20(9):1226-1238. PubMed ID: 31402321
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The major miR-31 target genes STK40 and LATS2 and their implications in the regulation of keratinocyte growth and hair differentiation.
    Luan L; Shi J; Yu Z; Andl T
    Exp Dermatol; 2017 Jun; 26(6):497-504. PubMed ID: 28419554
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. skin tumors with matrical differentiation: lessons from hair keratins, beta-catenin and PHLDA-1 expression.
    Battistella M; Carlson JA; Osio A; Langbein L; Cribier B
    J Cutan Pathol; 2014 May; 41(5):427-36. PubMed ID: 24673383
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increased HOX C13 expression in metastatic melanoma progression.
    Cantile M; Scognamiglio G; Anniciello A; Farina M; Gentilcore G; Santonastaso C; Fulciniti F; Cillo C; Franco R; Ascierto PA; Botti G
    J Transl Med; 2012 May; 10():91. PubMed ID: 22583695
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
    Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
    Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Expression of HOX C13 in odontogenic tumors].
    Hong YS; Wang J; Liu J; Zhang B; Hou L; Zhong M
    Shanghai Kou Qiang Yi Xue; 2007 Dec; 16(6):587-91. PubMed ID: 18278407
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression patterns of hair and epithelial keratins and transcription factors hoxc13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
    Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
    J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. On the regulation of hair keratin expression: lessons from studies in pilomatricomas.
    Cribier B; Peltre B; Grosshans E; Langbein L; Schweizer J
    J Invest Dermatol; 2004 May; 122(5):1078-83. PubMed ID: 15140206
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hox in hair growth and development.
    Awgulewitsch A
    Naturwissenschaften; 2003 May; 90(5):193-211. PubMed ID: 12743702
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.
    de Vries TJ; Trancikova D; Ruiter DJ; van Muijen GN
    Br J Cancer; 1998 Nov; 78(9):1156-61. PubMed ID: 9820172
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.